Skip to main content
Equibles

Vestal Point Capital, LP

Position in PALI — Palisade Bio, Inc.

CIK 1974915 NEW YORK, NY
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,225,000
+$850,000 QoQ
Shares Held
2,500,000
0.0% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#20
of 124 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vestal Point Capital, LP holds $2,824,321,683 across 51 Biotechnology names. PALI ranks #45 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 6,025,000 $344,750,500
2 ABVX
Abivax S.A.
 2,349,443 $313,086,774
3 ELVN
Enliven Therapeutics, Inc.
 4,000,000 $203,000,000
4 NRIX
Nurix Therapeutics, Inc.
 8,050,000 $195,293,000
5 BCAX
Bicara Therapeutics Inc.
 5,250,000 $155,872,500
6 TSHA
Taysha Gene Therapies, Inc.
 19,415,000 $132,216,150
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 1,575,000 $128,378,250
8 IRON
Disc Medicine, Inc.
 1,550,000 $113,367,000

All Filings in PALI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,225,000 2,500,000
2026-03-31 $4,375,000 2,500,000